Is a complete TYRA research report available?

No complete published report is available for Tyra Biosciences, Inc. (TYRA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Tyra Biosciences, Inc. (TYRA)

NASDAQ: TYRA · USD

$31.1

+0.23 (+0.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TYRA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.9B
Net income (ttm)	-131.1M
EPS (ttm)	-$2.18
Shares out	59.5M
Volume	496,078
Beta	0.76
Price target	$52.0	+67.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -131.1M
EPS (ttm): -$2.18
Market cap: 1.9B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TYRA indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001863127
Company name	Tyra Biosciences, Inc.
Country	United States
Country code	US
Cusip	90240B106
Employees	87
Employees Change	27%
Employees Change Percent	45
Enterprise value	$1.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-09-15
Isin	US90240B1061
Last refreshed	2026-07-30
Market cap	$1.9B
Market cap category	Small-Cap
Price	$31.11
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	TYRA
Website	https://tyra.bio

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.09%
FCF yield	-5.54%
P/B ratio	4.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-131.1M
Net Income Growth Years	0%
Profit Per Employee	$-1.5M
ROA	-23.64
Roa5y	-18.23
ROCE	-36.38
ROE	-36.87
Roe5y	-27.56
ROIC	-24.71

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	180.22%
Cagr3y	29.42%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$412M
Cash	$383.5M
Current Assets	$394.6M
Current Liabilities	$19.3M
Debt	$5.7M
Debt Equity	$0.01
Equity	$387.6M
Liabilities	$24.5M
Long Term Assets	$17.4M
Long Term Liabilities	$5.2M
Net Cash	$377.8M
Net Cash By Market Cap	$20.43
Net Cash Growth	20.76%
Net Debt Equity	$-0.97
Tangible Book Value	$387.6M
Tangible Book Value Per Share	$6.52
WACC	8.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	20.49
Net Working Capital	$-7.6M
Quick ratio	20.05
Working Capital	$375.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.05%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	180.02%
200-day SMA	28.69
3Y total return	116.79%
50-day SMA	30.72
50-day SMA vs 200-day SMA	50over200
All Time High	40.65
All Time High Change	-23.47%
All Time High Date	2026-04-01
All Time Low	4.93
All Time Low Change	531.03%
All Time Low Date	2022-06-21
ATR	1.7
Beta	0.76
Beta1y	0.19
Beta2y	1.3
Ch YTD	18.33
High	31.8
High52	40.65
High52 Date	2026-04-01
High52ch	-23.47%
Low	30.16
Low52	9.96
Low52 Date	2025-08-20
Low52ch	212.35%
Ma50ch	1.28%
Premarket Change Percent	2.72
Premarket Price	$31.72
Price vs 200-day SMA	8.45%
RSI	49.31
RSI Monthly	63.4
RSI Weekly	51.58
Sharpe ratio	1.95x
Sortino ratio	3.8
Total Return	-2.05%
Tr YTD	18.33
Tr1m	-2.42%
Tr1w	1.7%
Tr3m	-11.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	9
Analyst Price Target Top	$51
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.65
Operating Income	$-142.9M
Price target	$51.97
Price Target Change	$67.05
Price Target Change Top	$63.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	30,921,372%
Float Percent	51.99%
Shares Insiders	2.69%
Shares Institutions	65.97%
Shares Out	59,470,381
Shares Qo Q	3.19%
Shares Yo Y	2.05%
Short Float	32.12%
Short Ratio	10.26
Short Shares	16.7

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-131.9M
Adjusted OCF	-131,686,000
Average Volume	561,822.9x
Bv Per Share	6.52
CAPEX	$-215,000
Ch1m	-2.42
Ch1w	1.7
Ch1y	180
Ch3m	-11.27
Ch3y	116.8
Ch6m	0.1
Change	0.74%
Change From Open	-0.67
Close	30.88
Days Gap	1.42
Depreciation Amortization	541,000
Dollar Volume	15,432,986.6
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-142.9M
EBITDA	$-142.4M
EPS	$-2.18
F Score	1
FCF	$-102.5M
FCF EV Yield	-6.97x
FCF Per Share	$-1.72
Financing CF	166,296,000
Fiscal Year End	December
Founded	2,018
Investing CF	-79,807,000
Ipr	94.31
Iprfo	3.98
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	32.25
Ma150ch	-3.53%
Ma20	31.54
Ma20ch	-1.36%
Net CF	-15,766,000
Next Earnings Date	2026-08-13
Open	31.32
Optionable	Yes
Position In Range	57.93
Ppne	6,658,000
Pre Close	30.88
Price Date	2026-07-29
Ptbv Ratio	4.77
Relative Volume	0.88x
Share Based Comp	29,431,000
Tr6m	0.1%
Us State	California
Volume	496,078

Tyra Biosciences, Inc. (TYRA)

Coverage state: Market snapshot only — no published research

Generate the first TYRA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TYRA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TYRA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TYRA

Frequently asked questions